Steven Leonard Chapman - Mar 15, 2024 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
CEO AND PRESIDENT, Director
Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Mar 15, 2024
Transactions value $
-$6,081,128
Form type
4
Date filed
3/15/2024, 09:05 PM
Previous filing
Mar 7, 2024
Next filing
Apr 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise $284K +21.9K +8.85% $13.01 269K Mar 15, 2024 Direct
transaction NTRA Common Stock Options Exercise $561K +27.7K +10.29% $20.27 296K Mar 15, 2024 Direct
transaction NTRA Common Stock Options Exercise $477K +18.8K +6.32% $25.46 315K Mar 15, 2024 Direct
transaction NTRA Common Stock Sale -$1.75M -19.9K -6.32% $87.96 295K Mar 15, 2024 Direct F1, F2
transaction NTRA Common Stock Sale -$3.11M -35K -11.84% $88.98 260K Mar 15, 2024 Direct F1, F3
transaction NTRA Common Stock Sale -$2.54M -28.3K -10.88% $89.63 232K Mar 15, 2024 Direct F1, F4
holding NTRA Common Stock 50.9K Mar 15, 2024 By Rosewood Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Stock Option (right to buy) Options Exercise $0 -21.9K -91.3% $0.00 2.08K Mar 15, 2024 Common Stock 21.9K $13.01 Direct F6
transaction NTRA Stock Option (right to buy) Options Exercise $0 -27.7K -88.5% $0.00 3.6K Mar 15, 2024 Common Stock 27.7K $20.27 Direct F7
transaction NTRA Stock Option (right to buy) Options Exercise $0 -18.8K -100% $0.00* 0 Mar 15, 2024 Common Stock 18.8K $25.46 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.44 to $88.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.44 to $89.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.44 to $89.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The Rosewood Trust is an irrevocable spendthrift trust for the benefit of the Reporting Person and other discretionary beneficiaries, pursuant to Nevada Revised Statutes Chapter 166. Under the Rosewood Trust, the Reporting Person has no enforceable rights to distributions. The Rosewood Trust is a fully discretionary trust and the distribution decisions for the Rosewood Trust are vested in a committee. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F6 The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
F7 The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
F8 The option shares are fully exercisable.